top of page

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

COLVILLE, WA

58°F

Chance Light Rain

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

LETTERS TO THE EDITOR

Recent Quotes

My Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

NanoViricides, Inc. Common Stock (NY:NNVC)

1.410 +0.060 (+4.44%)

Delayed Quote Updated: 3:40 PM EST, Nov 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NanoViricides, Inc. Common Stock

< Previous 1 2 3 4 Next >

2 Small-Cap Biotechs That Could Reward Patient Investors ↗

December 12, 2025

Via MarketBeat

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 20, 2024

Via Benzinga

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 10, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 06, 2024

Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 16, 2024

Via Benzinga

NNVC Stock Earnings: Nanoviricides Beats EPS for Q3 2024 ↗

May 15, 2024

NNVC stock results show that Nanoviricides beat analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 06, 2024

Via Benzinga

3 Nanotech Stocks With the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Discover three nanotech stocks poised for explosive growth in a booming market. Explore their potential for massive returns.

Via InvestorPlace

A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment? ↗

January 31, 2024

Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.

Via Benzinga

NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024 ↗

January 08, 2024

NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco

Via Benzinga

Is This Ticker That InvestorsObserver Expects To Soar By More Than 350% Next Year On Your Watchlist?

December 01, 2023

--News Direct--

Via News Direct

Topics Death

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗

October 02, 2023

Read the latest report on NanoViricides here

Via Benzinga

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗

September 26, 2023

Read the latest report on NanoViricides here

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 22, 2023

Via Benzinga

SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19? ↗

July 18, 2023

Read the latest report on NanoViricides here.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 11, 2023

Via Benzinga

Why Are NanoViricides Shares Gaining Today ↗

July 11, 2023

NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for

Via Benzinga

Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?

July 11, 2023

Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?

Via News Direct

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.

Via Benzinga

Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target? ↗

July 10, 2023

Read the latest report on NanoViricides here.

Via Benzinga

NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment

July 06, 2023

NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment

Via News Direct

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Local News
Government
Business
Sports
Arts & Entertainment
Farm & Ranch
Great Outdoors
Profiles

Out of the Past
Letters to the Editor
Classifieds
Announcements
Events Calendar
Obituaries
Commissioner Agendas
Superior Court Dockets

Home

About

Contact

Advertising

Legal Notices

Terms of Use

Privacy Policy

Accessibility

Submissions

Place an Ad

Submit an Event

News Tips

Corrections

Letters to the Editor

Freelance Opportunities

Home Delivery

Join our Team

Statesman-Examiner

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

PHOTO GALLERY

Website Designed by Amber S. King – Creative Design

Home
About
Contact
Submissions

About
Contact
Place an Ad
Submissions
Freelance Opportunities
Join Our Team

bottom of page